GE HealthCare Technologies Inc. with ticker code (GEHC) have now 9 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target price and low target price is between 99 and 78 and has a mean target at $89.67. Given that the stocks previous close was at $68.36 this now indicates there is a potential upside of 31.2%. The 50 day MA is $77.60 and the 200 moving average now moves to $74.75. The company has a market capitalization of 31.37B. The current share price for the company is: 68.97 USD
The potential market cap would be $41,149,267,283 based on the market consensus.
The company has a dividend yield of 0.77%. Other points of data to note are a P/E ratio of 19.11, revenue per share of 41.86 and a 5.77% return on assets.
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The Company’s segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment includes medical devices, services, consumable products, services, and digital solutions. The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the global radiology and nuclear medicine industry.
